← Open Payments lookup

STEPHEN VOBACH: Open Payments

NPI 1851377006 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$49,701 in 279 payments from 21 companies in 2025. Trend: 2023 $72,718 · 2024 $40,038 · 2025 $49,701

Speaker / faculty: $43,560Food & beverage: $4,670Travel & lodging: $1,472
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.51$25,517
ABBVIE INC.46$21,040
Otsuka America Pharmaceutical, Inc.24$469
Neurocrine BioSciences, Inc.27$459
Axsome Therapeutics, Inc.22$435
Alkermes, Inc.15$277
Lundbeck LLC16$241
Bausch Health US, LLC13$186
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)12$165
Corium, LLC10$160

Products named: FANAPT, VRAYLAR, REXULTI, INGREZZA, Auvelity, ARISTADA, CAPLYTA, Azstarys.

Industry payments across TX — which companies pay providers there.